Notice: This company has been marked as potentially delisted and may not be actively trading. Cinedigm (CIDM) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CIDM vs. BTX, ALFIW, and NLOKShould you be buying Cinedigm stock or one of its competitors? The main competitors of Cinedigm include Brooklyn ImmunoTherapeutics (BTX), Alfi (ALFIW), and NortonLifeLock (NLOK). These companies are all part of the "information" sector. Cinedigm vs. Brooklyn ImmunoTherapeutics Alfi NortonLifeLock Brooklyn ImmunoTherapeutics (NYSE:BTX) and Cinedigm (NASDAQ:CIDM) are both small-cap information companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk, analyst recommendations and community ranking. Does the MarketBeat Community believe in BTX or CIDM? Brooklyn ImmunoTherapeutics and Cinedigm both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBrooklyn ImmunoTherapeuticsOutperform VotesNo VotesUnderperform Votes99100.00% CinedigmOutperform VotesNo VotesUnderperform Votes61100.00% Is BTX or CIDM more profitable? Company Net Margins Return on Equity Return on Assets Brooklyn ImmunoTherapeuticsN/A N/A N/A Cinedigm N/A N/A N/A Does the media prefer BTX or CIDM? In the previous week, Brooklyn ImmunoTherapeutics had 1 more articles in the media than Cinedigm. MarketBeat recorded 1 mentions for Brooklyn ImmunoTherapeutics and 0 mentions for Cinedigm. Brooklyn ImmunoTherapeutics' average media sentiment score of 0.00 equaled Cinedigm'saverage media sentiment score. Company Overall Sentiment Brooklyn ImmunoTherapeutics Neutral Cinedigm Neutral Which has more volatility and risk, BTX or CIDM? Brooklyn ImmunoTherapeutics has a beta of 4.61, indicating that its share price is 361% more volatile than the S&P 500. Comparatively, Cinedigm has a beta of 2.05, indicating that its share price is 105% more volatile than the S&P 500. Which has stronger valuation and earnings, BTX or CIDM? Brooklyn ImmunoTherapeutics has higher earnings, but lower revenue than Cinedigm. Cinedigm is trading at a lower price-to-earnings ratio than Brooklyn ImmunoTherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-0.11Cinedigm$72.33M9.10-$9.35M-$0.05-70.40 Do insiders & institutionals have more ownership in BTX or CIDM? 26.0% of Brooklyn ImmunoTherapeutics shares are owned by institutional investors. Comparatively, 8.0% of Cinedigm shares are owned by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are owned by insiders. Comparatively, 16.4% of Cinedigm shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryBrooklyn ImmunoTherapeutics beats Cinedigm on 5 of the 7 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Cinedigm News Delivered to You Automatically Sign up to receive the latest news and ratings for CIDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart CIDM vs. The Competition Export to ExcelMetricCinedigmMotion Picture and Video Production IndustryInformation SectorNASDAQ ExchangeMarket Cap$657.94M$500.93M$5.33B$9.08BDividend YieldN/AN/A3.69%4.23%P/E Ratio-70.40N/A7.1217.18Price / Sales9.106.935.64116.99Price / CashN/AN/AN/A37.86Price / BookN/AN/AN/A4.78Net Income-$9.35MN/AN/A$225.60M Cinedigm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CIDMCinedigmN/A$3.52+3.2%N/A+212.8%$657.94M$72.33M-70.40140Analyst ForecastGap DownBTXBrooklyn ImmunoTherapeuticsN/A$4.10+0.0%N/A-83.7%$241.30MN/A-0.09N/AALFIWAlfiN/A$0.04-21.0%N/AN/A$0.00$200,684.000.0040Gap DownHigh Trading VolumeNLOKNortonLifeLock0.7545 of 5 stars$29.86-0.5%N/A+17.9%$17.06B$2.82B20.88N/A Related Companies and Tools Related Companies BTX Competitors ALFIW Competitors NLOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CIDM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cinedigm Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Cinedigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CIDM Stock Alerts